180 Life Sciences Corp. Warrant

$1.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-3.19%) Today
-$0.10 (-5.49%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can watch ATNFW and buy or sell other stocks, options, and ETFs commission-free!

About ATNFW

180 Life Sciences Corp. develops pharmaceuticals for chronic pain and inflammatory diseases. It operates as a clinical-stage biotechnology company focused on the development of novel drugs that fulfil unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University.

CEO
Jim N. Woody, MD, PhD
Employees
—
Headquarters
Menlo Park, California
Founded
2016
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
672.32K
High Today
$2.01
Low Today
$1.64
Open Price
$1.82
Volume
538.53K
52 Week High
$2.97
52 Week Low
$0.13

You May Also Like

SPRB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure